PULM
Pulmatrix Inc
NASDAQ: PULM · HEALTHCARE · BIOTECHNOLOGY
$1.26
+1.61% today
Updated 2026-04-30
Market cap
$4.67M
P/E ratio
—
P/S ratio
2,459.21x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$1 – $9
Volume
0.1M
Pulmatrix Inc (PULM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-80.90%
ROA
-45.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-30000.00 | — | — | — |
| 2012 | $653000.00 | $-523000.00 | -1,211.49% | -80.09% | -80.09% |
| 2013 | $352000.00 | $-3.12M | -1,772.16% | -885.80% | -885.80% |
| 2014 | $352000.00 | $-24.14M | -1,772.16% | -2,578.41% | -6,859.09% |
| 2015 | $1.20M | $-26.17M | -498.42% | -1,916.57% | -2,178.77% |
| 2016 | $835000.00 | $-27.84M | -1,115.81% | -2,977.96% | -3,334.49% |
| 2017 | $335000.00 | $-18.06M | -2,957.61% | -5,216.42% | -5,389.85% |
| 2018 | $153000.00 | $-20.56M | -8,374.51% | -13,288.24% | -13,439.87% |
| 2019 | $7.91M | $-20.60M | -62.39% | -261.59% | -260.38% |
| 2020 | $12.63M | $-19.31M | 100.00% | -78.06% | -152.83% |
| 2021 | $5.17M | $-20.17M | -197.58% | -390.15% | -390.23% |
| 2022 | $6.07M | $-18.73M | 100.00% | -312.09% | -308.43% |
| 2023 | $7.30M | $-14.12M | -112.63% | -201.97% | -193.49% |
| 2024 | $7.81M | $-9.56M | 8.20% | -125.07% | -122.46% |
| 2025 | $0.00 | $-5.16M | — | — | — |